Carcinogenicity studies in rodents with ripazepam, a minor tranquilizing agent
dc.contributor.author | Fitzgerald, J. E. | en_US |
dc.contributor.author | de la Iglesia, Felix A. | en_US |
dc.contributor.author | McGuire, Edward J. | en_US |
dc.date.accessioned | 2006-04-07T18:29:14Z | |
dc.date.available | 2006-04-07T18:29:14Z | |
dc.date.issued | 1984-04 | en_US |
dc.identifier.citation | Fitzgerald, J. E., de la Iglesia, F. A., McGuire, E. J. (1984/04)."Carcinogenicity studies in rodents with ripazepam, a minor tranquilizing agent." Fundamental and Applied Toxicology 4(2, Part 1): 178-190. <http://hdl.handle.net/2027.42/24852> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6WFT-4DDP5WG-CX/2/c49c6ef89f4a5abc91070d157918e718 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/24852 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=6724192&dopt=citation | en_US |
dc.description.abstract | The carcinogenesis potential of ripazepam, a benzodiazepine derivative, was studied in mice and rats for 78 and 104 weeks, respectively. Groups of 50 male and 50 female CD1 mice and CD rats each were given doses of 15 and 150 mg/kg of ripazepam in the diet. Survival rates were adequate for statistical analysis. Significant suppression of body weight gains occurred in rats but not in mice given 150 mg/kg/day. The compound failed to increase tumor rates or alter the average latency of neoplasms in the rat. In mice, the number of male animals with tumors was increased at 150 mg/kg and this was related to a significant increase in the number of animals with hepatocellular tumors. Hepatocellular tumors were increased also in female mice but the increase was not statistically significant. All but one of these hepatic neoplasms were hepatocellular adenomas and the one carcinoma had not metastasized. Other tumor types were not increased. | en_US |
dc.format.extent | 3578917 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Carcinogenicity studies in rodents with ripazepam, a minor tranquilizing agent | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationother | Department of Pathology and Experimental Toxicology, Warner-Lambert/Parke-Davis Pharmaceutical Research, Warner-Lambert Company, Ann Arbor, Michigan 48105, USA | en_US |
dc.contributor.affiliationother | Department of Pathology and Experimental Toxicology, Warner-Lambert/Parke-Davis Pharmaceutical Research, Warner-Lambert Company, Ann Arbor, Michigan 48105, USA | en_US |
dc.contributor.affiliationother | Department of Pathology and Experimental Toxicology, Warner-Lambert/Parke-Davis Pharmaceutical Research, Warner-Lambert Company, Ann Arbor, Michigan 48105, USA | en_US |
dc.identifier.pmid | 6724192 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/24852/1/0000279.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0272-0590(84)90118-0 | en_US |
dc.identifier.source | Fundamental and Applied Toxicology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.